Stay updated on Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial
Sign up to get notified when there's something new on the Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial page.
Latest updates to the Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check23 days agoChange DetectedThe website has updated the intervention details to include a verified status from 2022 and has upgraded to revision v2.14.0, while the previous type of intervention has been removed in revision v2.13.3.SummaryDifference0.5%
- Check52 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check60 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference1%
- Check74 days agoChange DetectedSeveral key URLs related to genetics, lung cancer, and medical research have been removed, indicating a potential shift in focus or resource availability on the website.SummaryDifference3%
Stay in the know with updates to Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial page.